Instituto Universitario de Investigación en Neuroquímica
Centre/Institut
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario Marqués de Valdecilla (15)
2024
-
Decreased oxytocin plasma levels and oxytocin receptor expression associated with aggressive behavior in aggressive-impulsive disorders
Journal of Psychiatric Research, Vol. 170, pp. 200-206
-
Inflammatory profiles in women with eating disorder: Linking inflammatory biomarkers to clinical phenotypes
Psychoneuroendocrinology, Vol. 162
-
Transdiagnostic inflammatory and oxidative biomarkers with predictive capacity of self-injurious behavior in impulsive and unstable disorders
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 130
2023
2022
-
Dysfunction of Inflammatory Pathways and Their Relationship With Psychological Factors in Adult Female Patients With Eating Disorders
Frontiers in Pharmacology, Vol. 13
-
Examining the immune signatures of SARS-CoV-2 infection in pregnancy and the impact on neurodevelopment: Protocol of the SIGNATURE longitudinal study
Frontiers in Pediatrics, Vol. 10
2021
-
COVID-19 as a unique opportunity to unravel the link between prenatal maternal infection, brain development and neuropsychiatric disorders in offspring
Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 1, pp. 1-3
2020
-
Expression and functionality study of 9 toll-like receptors in 33 drug-naïve non-affective first episode psychosis individuals: A 3-month study
International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-13
2018
-
Comparison of the anti-inflammatory effect of aripiprazole and risperidone in 75 drug-naïve first episode psychosis individuals: A 3 months randomized study
Schizophrenia Research, Vol. 202, pp. 226-233
2017
-
Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation
ACS Chemical Neuroscience, Vol. 8, Núm. 11, pp. 2393-2401
2015
-
Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain
Brain
-
Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures
Oncotarget, Vol. 6, Núm. 28, pp. 25452-25465
2014
-
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study
Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29
2012
2006
-
Cannabinoid receptors as novel targets for the treatment of melanoma
FASEB Journal, Vol. 20, Núm. 14